Navigation Links
XTENT to Present at Cowen and Company's 28th Annual Health Care Conference
Date:3/12/2008

MENLO PARK, Calif., March 12 /PRNewswire-FirstCall/ -- XTENT, Inc. (Nasdaq: XTNT) today announced that Gregory D. Casciaro, President and Chief Executive Officer, will present at Cowen and Company's 28th Annual Health Care Conference on Tuesday, March 18, 2008 at 9:30 a.m. Eastern. This event will be held at the Boston Marriot Copley Place in Boston, MA.

About XTENT

XTENT, Inc. is a medical device company focused on developing and commercializing innovative customizable drug eluting stent (DES) systems for the treatment of coronary artery disease (CAD). CAD is the most common form of cardiovascular disease and the number one cause of death in the United States and Europe. XTENT(R) Custom NX(R) DES Systems are designed to enable the treatment of single lesions, long lesions and multiple lesions of varying lengths and diameters, in one or more arteries with a single device. Note: XTENT Custom NX DES Systems have not been approved for sale by any regulatory authority.

Information about XTENT is available at our website at http://www.xtentinc.com.


'/>"/>
SOURCE XTENT, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. XTENT Announces 2007 Financial Results
2. New study shows extent of harmful human influences on global ecosystems
3. XTENT Announces 2007 Financial Results Conference Call
4. XTENT Submits CE Mark Registration to Market Custom NX(R) Drug-Eluting Stent System in Europe
5. XTENT Announces Third Quarter 2007 Financial Results
6. MedCath Corporation to Present at the Citi 2008 Small and Mid-Cap Conference
7. Onyx Pharmaceuticals to Present at Lehman Brothers Global Healthcare Conference
8. Mettler-Toledo International Inc. Announces Webcast of Presentation at Lehman Brothers Global Healthcare Conference
9. Zimmer Holdings to Present at Upcoming Investor Conferences
10. Idenix Pharmaceuticals to Present at the Eleventh Annual Lehman Brothers Global Healthcare Conference
11. Edwards Lifesciences to Present at the Cowen and Company Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/7/2016)... ... ... “Fred Rides a Train” allows readers to tag along on a special shopping trip ... the creation of published author, Janet Morrison, who has been writing mostly poetry, essays, ... Dog" series is her first attempt at writing for children. Janet, Fred, and two ...
(Date:12/7/2016)... ... 2016 , ... The Business Architecture Guild is ... on March 21-22, 2017. This premier event features business practitioners and experts from ... of industries such as financial services, insurance, healthcare, manufacturing, transportation, retail, and utilities. ...
(Date:12/7/2016)... ... December 07, 2016 , ... NuevaCare, a leading home care ... proud to announce new city-specific pages as part of its ambitious website relaunch. As ... often look, first, for local agencies serving their city. The new site has several ...
(Date:12/6/2016)... ... December 06, 2016 , ... People with ... be seen on a type of MRI, according to a study appearing online ... the central nervous system characterized by tremors or trembling and stiffness in the ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... of a higher risk of serious health problems, such as cardiovascular illness, according ... Peiman Soleymani of Beverly Hills Periodontics & Dental Implant Center notes that the ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016 Two new disaster drones ... a simulated mass casualty event Tuesday at John Bell ... technology debuted before an audience including Mississippi ... from Homeland Security, Federal Law Enforcement Agencies, and the ... as HiRO (Health Integrated Rescue Operations), was developed by ...
(Date:12/6/2016)... , Dec. 6, 2016  Arcturus Therapeutics, Inc. ... company, announced today that it entered into collaboration ... therapeutics for the treatment of NASH and other ... delivery platform LUNAR™ and UNA Oligomer chemistry. The ... Takeda,s long-standing commitment to and expertise in GI ...
(Date:12/6/2016)... Dec. 6, 2016  Blueprint Medicines Corporation (NASDAQ: ... targeted kinase medicines for patients with genomically defined diseases, ... offering of $125,000,000 million in shares of its common ... underwriters a 30-day option to purchase up to an ... stock in connection with the public offering. All shares ...
Breaking Medicine Technology: